No Data
No Data
There's Been No Shortage Of Growth Recently For Cross Country Healthcare's (NASDAQ:CCRN) Returns On Capital
Cross Country's Susan E. Ball Recognized on SIA's Global Power 150 Women in Staffing
Jefferies Initiates Cross Country Healthcare(CCRN.US) With Hold Rating, Announces Target Price $12
UBS Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Cuts Target Price to $14
Express News | Cross Country Healthcare Inc : UBS Cuts Target Price to $14 From $19
Cross Country Healthcare | 10-Q: Q3 2024 Earnings Report
No Data
No Data